BUBR1 Activators

BUBR1, a crucial component of the mitotic checkpoint, plays a pivotal role in ensuring accurate chromosome segregation during cell division. The chemicals selected as potential BUBR1 activators exert their effects by modulating key cellular pathways involved in the regulation of this essential protein. 6-Bromoindirubin-3'-oxime is a potent activator that indirectly influences BUBR1 through the inhibition of GSK-3β. GSK-3β is a negative regulator of BUBR1, promoting its phosphorylation-dependent degradation. By inhibiting GSK-3β, 6-Bromoindirubin-3'-oxime stabilizes BUBR1 expression, preventing its degradation and thus activating its mitotic checkpoint function. AZD5438 operates as a BUBR1 activator by selectively inhibiting cyclin-dependent kinases (CDKs). Through its impact on the cell cycle, AZD5438 stabilizes and increases the expression of BUBR1. This process occurs as a result of CDK inhibition, preventing BUBR1 from being targeted for degradation and enhancing its presence during mitosis.

VX-680 (Tozasertib), a potent inhibitor of Aurora kinases, indirectly activates BUBR1 by impacting mitotic progression. BUBR1 stability is tightly regulated during mitosis, and inhibiting Aurora kinases with VX-680 prevents the degradation of BUBR1, leading to increased protein levels and activation of its mitotic checkpoint functions. BI 2536 is a highly selective inhibitor of Polo-like kinase 1 (PLK1), a key player in mitotic regulation. By inhibiting PLK1, BI 2536 indirectly activates BUBR1, as PLK1 is involved in the control of BUBR1 degradation during mitosis. Stabilizing BUBR1 expression contributes to the efficient functioning of the mitotic checkpoint. SB218078, a specific PLK4 inhibitor, influences centrosome duplication, a process tightly linked to mitotic regulation. Inhibition of PLK4 by SB218078 indirectly activates BUBR1 by modulating centrosomal integrity, which in turn affects the stability and expression of BUBR1 during cell division. These activators collectively provide valuable tools for studying the intricate regulatory mechanisms of the mitotic checkpoint, shedding light on the precise ways in which BUBR1 is modulated.